Radiopharmaceuticals Market Size PowerPoint PPT Presentations

The growth of global radiopharmaceutical market is attributed to the factors such as increase in the number of patients of cancer, dementia and Alzhimer’s Parkinson and increase in demand from developing countries attributed to non-invasiveness procedures.

The global Radiopharmaceuticals/Nuclear Medicine Market was valued at US$ 5605 Million in 2022 and is anticipated to grow at US$ 9327 Million by 2029 recording a CAGR of 9.3% during the forecast period 2023-2029. Request sample report at https://www.precisionbusinessinsights.com/request-sample/?product_id=17441

The radiopharmaceuticals market is then expected to grow at a CAGR of 5.6% from 2025 and reach $7,507.3 million in 2030.

Global Radiopharmaceuticals Market by The Business Research Company is segmented as Oncology, Cardiology, Gastroenterology, Neuroendocrinnology, Neurology https://bit.ly/3iywX58

Diagnostic Radiopharmaceuticals & Contrast Media market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Diagnostic Radiopharmaceuticals & Contrast Media market will be able to gain the upper hand as they use the report as a powerful resource.

Prevalence of diseases such as cancer and cardiovascular diseases are increasing rapidly across the globe due to aging population, unhealthy food habits, and rising obesity. For instance, according to the American Heart Association, cardiovascular diseases alone accounts for 17.3 million deaths each year, which is more than the deaths caused due to cancer.

The global radiopharmaceuticals market size was valued at $5.2 billion in 2022, and is projected to reach $13.7 billion by 2032, growing at a CAGR of 10.2% from 2023 to 2032.

Radiopharmaceutical is a radioactive pharmaceutical agent which is used diagnostic or therapeutic procedures. A radiopharmaceutical is made up of two components that are drug component and radioactive component.

Radiopharmaceutical is a radioactive pharmaceutical agent which is used diagnostic or therapeutic procedures. A radiopharmaceutical is made up of two components that are drug component and radioactive component.

The radiotherapy market is projected to reach US$ 10,170.80 million by 2028 from US$ 6,474.78 million in 2020; it is estimated to grow at a CAGR of 5.9% from 2021 to 2028.

Global Radiopharmaceutical Theragnostics Market Forecast to 2028 – COVID-19 Impact and Analysis – by Product Type, Radioisotope, Source, Application, Indication, and End User,” the market is expected to grow from US$ 1,814.58 million in 2022 to US$ 3,441.97 million by 2028; it is estimated to grow at a CAGR of 11.3% from 2022 to 2028

In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Nuclear Medicine/Radiopharmaceuticals Report by Material, Application, and Geography Global Forecast to 2023 is a professional and comprehensive research report on the worlds major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, United Kingdom, Japan, South Korea and China).

This report studies the global market size of Radiopharmaceuticals in Nuclear Medicine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Radiopharmaceuticals in Nuclear Medicine in these regions.

Latest research Radiopharmaceuticals Market, released by The Business Research Company with 130+ pages of analysis on business strategy and emerging industry players. https://bit.ly/3mmqkmo

The nuclear medicine/radiopharmaceuticals market is projected to reach USD 7.27 billion by 2021 from USD 4.67 billion in 2016, growing at a CAGR of 9.3% in the next five years (2016 to 2021).

The Global And China Radiopharmaceuticals Industry 2017 Market Research Report is a professional and in-depth study on the current state of the Radiopharmaceuticals industry.

According to #TechSci Research report, Global Nuclear Imaging Equipment Market stood at USD4054.46 million in 2020 and is expected to grow at a CAGR of 6.51% by 2026. Gain More Insight: https://bit.ly/3v29zB4 Get Sample Report: https://bit.ly/3KdYyVJ Press Release: https://bit.ly/3LGMv3y Website: https://www.techsciresearch.com/ Market Research News: https://techsciblog.com/

The Radiopharmaceutical/Nuclear Medicine Market Report offers a complete picture of industry trends and factors along with quantitative data based on historical data and from various sources. Apart from this, the report also provides the market outlook, growth, share, size, opportunity and forecast during 2019-2025. Further, the report focuses on competitive landscape including company profiles of leading key players along with industry demand, future capacities, key mergers & acquisitions, financial overview in the global market of radiopharmaceutical/nuclear medicine.

This report studies the European nuclear medicine/radiopharmaceuticals market for the forecast period of 2015 to 2020. This market is expected to reach $1.62 Billion by 2020 from $1.09 Billion in 2015, at a CAGR of 8.2% during the forecast period (2015 to 2020).

Radiopharmaceuticals in Nuclear Medical market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Radiopharmaceuticals in Nuclear Medical market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.

Big Market Research “Global Contrast MediaContrast Agents Market” Size, Share, Industry Trends, Demand, Insights, Analysis, Research, Report, Opportunities, Company Profiles, Forecast to 2019. Visit for more info @ http://www.bigmarketresearch.com/global-contrast-mediacontrast-agents-2015-2019-market Contrast mediacontrast agents are chemicals used in diagnostic imaging procedures such as CT scans, MRIs, X-rays, ultrasounds, and related procedures. They enhance the internal structure of the body and provide high-quality images, which help in providing an accurate diagnosis. It is widely used in radiology, interventional radiology, and interventional cardiology.

The Global Contrast Media Market size is expected to reach $6.3 billion by 2025, rising at a market growth of 3.52% CAGR during the forecast period. Free Valuable Insights: https://www.kbvresearch.com/contrast-media-market/

Radiopharmaceuticals are pharmaceutical formulations comprising radioactive isotopes that are used in diagnosis and therapeutics. They are simple and small substances that contain a radioactive substance that is used in the treatment of cancer and cardiac & neurological disorders.

The global nuclear medicine equipment market size reached US$ 3.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 5.2 Billion by 2032, exhibiting a growth rate (CAGR) of 5.8% during 2024-2032. More Info:- https://www.imarcgroup.com/nuclear-medicine-equipment-market

Global central nervous system biomarkers market size is expected to reach $8.02 Bn by 2028 at a rate of 9.7%, segmented as by type, safety biomarker, efficacy biomarker, validation biomarker, other types

Positron Emission Tomography Market report gives attention to market segmentation, market size, and forecast of 2023-2032 to help stakeholders in making a good decision for the future investments. Urinary Catheters industry report segmented into types, application, and regions with providing production, revenue, import/export.

According to the latest research report by IMARC Group, The global alpha emitter market size reached US$ 1,476.8 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 10,975.8 Million by 2032, exhibiting a growth rate (CAGR) of 24.22% during 2024-2032. More Info:- https://www.imarcgroup.com/alpha-emitter-market

The Business Research Company offers nuclear medicine diagnostics market research report 2023 with industry size, share, segments and market growth

Global radiopharmaceutical theranostics market size is expected at $4.25 Bn by 2027 at a growth rate of 14.11%.

According to the latest research report by IMARC Group, The global nuclear medicine equipment market size reached US$ 2.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.3 Billion by 2028, exhibiting a growth rate (CAGR) of 6.65% during 2023-2028. More Info:- https://www.imarcgroup.com/nuclear-medicine-equipment-market

According to the latest research report by IMARC Group, The global positron emission tomography market size reached US$ 1,084 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,512 Million by 2028, exhibiting a growth rate (CAGR) of 5.9% during 2023-2028. More Info:- https://www.imarcgroup.com/positron-emission-tomography-market

Nuclear Medicine Equipment Market size is estimated to reach $2.3 billion by 2027, growing at a CAGR of 3.9% during the forecast period 2022-2027.

The Asia-Pacific nuclear medicine market size was valued at $4,116.43 million in 2020, and is projected to reach $8,957.89 million by 2028, registering a CAGR of 10.4% from 2021 to 2028.

The Asia-Pacific nuclear medicine market size was valued at $4,116.43 million in 2020, and is projected to reach $8,957.89 million by 2028, registering a CAGR of 10.4% from 2021 to 2028.

Genitourinary Drugs Market size will witness a considerable growth over the forecast period. Get more details @ https://goo.gl/AFy1qd

Get more details @ http://bit.ly/2oX0vzB Genitourinary Drugs Market Size, Industry Analysis Report, Regional Outlook (U.S., Germany, UK, Italy, Russia, China, India, Japan, South Korea, Brazil, Mexico, Saudi Arabia, UAE, South Africa), Application Growth Potential, Competitive Market Growth & Forecast, 2016 – 2024

A new report available with decisiondatabases.com on RadiopharmaceuticalsMarket which provides an in-depth analysis during the forecast period. This report focuses on top manufactures with capacity, production, price, revenue and Market share.

Looking forward, the nuclear medicine equipment market value is projected to reach a strong growth during the forecast period (2022-2027). More info:- https://www.imarcgroup.com/nuclear-medicine-equipment-market

Automated Radiosynthesis modules drive the production of radiotracer for PET and SPECT (Single-Photon Emission Computed Tomography) imaging in decentralized settings. These modules are user friendly, simple to set up, and offer scope of customized formulations of radiotracer for diagnostic and therapy administration, and hence their adoption will be increasing in near future. Automated Radiosynthesis Modules Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $32 million by 2022, registering a CAGR of 6.6% during the period 2016 - 2022.North America accounted for the largest share in terms of both market revenues and unit volumes, whereas Asia-Pacific region is expected to witness fastest growth rate during the forecast period. Read Full Report here: https://www.alliedmarketresearch.com/automated-radio-synthesis-modules-market Download Sample report @ https://www.alliedmarketresearch.com/request-free-sample/1761

Looking forward, the positron emission tomography (PET) market value is projected to reach a strong growth during the forecast period (2022-2027). More info:- https://www.imarcgroup.com/positron-emission-tomography-market

According to the latest research by PMR, the global PET/CT systems market is expected to account for more than 3.0 billion US$ in terms of value, by the end of 2028. The PET/CT systems report also projects a significant growth potential, with an average Y-O-Y growth rate pegged at 6.2% through 2028.

Get more details @ http://bit.ly/2zKasVN Some of the major players in vaccines market are AstraZeneca, Abbott, Bristol-Myers Squibb, Merck & Co., Johnson & Johnson, Sanofi Pasteur, Pfizer, GlaxoSmithKline, Emergent BioSolutions, Novartis, Astellas Pharma, CSL and Novavax.

Looking forward, the positron emission tomography market value is projected to reach a strong growth during the forecast period (2021-2026). More info:- https://www.imarcgroup.com/positron-emission-tomography-market

Castration-Resistant Prostate Cancer (CRPC) or Hormone Refractory Prostate Cancer (CRPC), a type of prostate cancer that typically recurs after administering androgen deprivation therapy (ADT), is gaining prominence in the prostate cancer market. The global CRPC market is poised to expand at a significant pace, owing to high unmet clinical need, limited survival benefits, growing prevalence rates and fast emerging treatment modifications.

Medical imaging reagents play a vital role in pharmaceuticals, diagnostic, biotechnology life science and medical industries. These reagents are specially designed to enhance images quality formed through imaging systems.

In the past few years, more efficient therapeutic nuclear medicines have been launched, which have shown positive results for the treatment of various types of cancer. For instance, the launch of Xofigo (Radium-223) by Bayer for the treatment of prostate cancer and the launch of Lutathera (Lutetium-177) for the treatment of neuroblastoma and synovitis has created growth opportunities for the therapeutic nuclear medicines market over the forecast period.

The global radiopharmaceuticals market size is projected to reach USD 9.54 billion by 2026. According to a report published by Fortune Business Insights, titled “Radiopharmaceuticals Market Size, Share & Industry Analysis, By Type (PET Radiopharmaceuticals, SPECT Radiopharmaceuticals), By Application (Neurology, Cardiology, Oncology, and Others), By End User (Hospitals & Clinics, Diagnostic Centres, and Others) and Regional Forecast, 2019-2026,” the market was valued at USD 4.86 billion in 2018. Driven by increasing number of successful clinical trials, the market will exhibit a CAGR of 9.0% from 2019-2026. For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/nuclear-medicine-radiopharmaceuticals-market-101812

2019 Analysis and Review of Radiopharmaceuticals Market by Application - Oncology, Cardiology, Gastroenterology, Neuroendocrinology, Neurology, and Nephrology for 2019 - 2029

This market is expected to reach $1.62 Billion by 2020 from $1.09 Billion in 2015, at a CAGR of 8.2% during the forecast period (2015 to 2020).

Press Release on “Nuclear Medicine/Radiopharmaceuticals market- Size, Share, Trends Forecast 2022” added by Research Trades to its database. In this report, the global Nuclear Medicine/Radiopharmaceuticals market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Get Sample Copy of this report @ http://www.researchtrades.com/request-sample/1086022

Global radiotherapy market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is expected to grow with a CAGR of 6.4% in the forecast period of 2022 to 2029 and is expected to reach USD 12,194.17 million by 2029 from USD 7,537.29 million in 2021.

Marketreportsonchina.com presents a report on “Global Central Nervous System Biomarkers : Segmentation and Forecast 2015 - 2021”. http://www.marketreportsonchina.com/life-sciences-market-research-reports-18404/global-central-nervous-system-biomarkers-by-united-states-canada-india-china-japan-united-kingdom.html The global market value of the Global CNS Biomarker market is expected to be a billion dollar opportunity by 2015.

The nuclear medicine is an intricate branch of medical science that uses radiopharmaceuticals for detection and diagnostic procedures. The radiopharmaceuticals consist of radioisotopes produced through particle accelerator such as the medical cyclotron and are used for targeted therapy, detection based imaging and therapeutics. With advancement in medical technology, the imaging and diagnostic devices have evolved significantly.

An introduction to MedicinesComplete * * * Remember me function allows users to log in once and remain logged in. Market focused product information allows ...

Part 2: Practical Applications of Radionuclides. Current Radiopharmaceuticals ... Longer alkyl chain (X,Y, Z) attenuate liver uptake. Phenyl ring (Lipophillic) ...

Global clinical trials imaging market @ http://tinyurl.com/jld56aj . Growth in pharmaceutical & biotechnology industries increase in R&D funding and increasing number of CROs are the primary growth drivers for this market during the forecast period (2015–2020). It is expected to reach USD 981.53 Million by 2020 from USD 724.87 Million in 2015, growing at a CAGR of 6.25%. The global clinical trials imaging market is segmented on the basis of products, modality and end-users. On the basis of products, the market is segmented into services & software.